Benefits

首页> 外文期刊>Professional safety >Benefits

【24h】

Benefits

机译：好处

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The new standard covers more than 43 million workers who produce or handle hazardous chemicals in more than 5 million workplaces across the country. Once fully implemented, the standard is expected to: 1. prevent more than 500 workplace injuries and illnesses and 43 fatalities annually; 2. improve the quality and consistency of hazard information, making it safer for workers to do their jobs and easier for employers to stay competitive.

机译：新标准涵盖了超过4,300万在全国超过500万个工作场所生产或处理危险化学品的工人。一旦全面实施，该标准有望：1.每年预防500多个工作场所的伤害和疾病，并避免43人死亡； 2.提高危险信息的质量和一致性，使工人更安全地工作，并使雇主更容易保持竞争力。

著录项

来源
《Professional safety》 |2012年第5期|p.16|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Benefits from hazards, benefits from nothing, and benefits from benefits: the combined effects of five quaternary ammonium compounds to Vibrio qinghaiensis Q67 [J] . Ling-Yun Mo, Yong-An Liu, Jie Zhu, Environmental sciences Europe . 2020,第1期

机译：从危险中受益，没有任何益处，以及益处的益处：五季铵化合物对vibrio的综合作用q67
2. Comparison of de novo IgM and IgG anti‐ HLA DSAs HLA DSAs between belatacept‐ and calcineurin‐treated patients: An analysis of the BENEFIT BENEFIT and BENEFIT BENEFIT ‐ EXT EXT trial cohorts [J] . Everly Matthew J., Roberts Mustimbo, Townsend Robert, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2018,第9期

机译：BelataCept-in钙素治疗患者De Novo IgM和IgG抗HLA DSAS HLA DSA的比较：福利益处和福利益处分析 - 勘探勘察队伍
3. Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT BENEFIT and BENEFIT BENEFIT ‐ EXT EXT [J] . Bray R. A., Gebel H. M., Townsend R., American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2018,第7期

机译：在BelataCept - 与环孢菌素的免疫抑制之后预先存在的供体特异性抗体水平的后翻版物：HOC效益和福利益处的后HOC分析 - EXT EXT
4. A Benefit Transfer Approach to Evaluate Livability Benefits of Transit Projects in Benefit-Cost Analysis [C] . Kate Ko Transportation Research Board Annual meeting . 2013

机译：效益成本分析中评估过境项目宜居效益的收益转移方法
5. Estimating the Economic Benefits of a Mt St Helens Wolf Population: a Cost Benefit Analysis Using Benefit Transfer. [D] . Schoellhamer, Matthew. 2013

机译：估计圣海伦狼山人口的经济效益：使用收益转移的成本收益分析。
6. Promoting Reflection on Medical Maximizing-Minimizing Preferences May Create Undesired Effects on Decisions About Low-Benefit and High-Benefit Care [O] . Brian J. Zikmund-Fisher, Victoria A. Shaffer, Laura D. Scherer 2021

机译：促进医学最大化最小化偏好的反思可能会对关于低利益和高效护理的决定产生不期望的影响
7. ANALISIS PERAN FUNCTIONAL BENEFITS, SYMBOLIC BENEFITS, EXPERIENTIAL BENEFITS DAN CUSTOMER SATISFACTION SEBAGAI PEMBENTUK LOYALTY INTENTION PADA CUSTOMER THE BODY SHOP (TELAAH PADA: THE BODY SHOP DI WILAYAH JAKARTA) [O] . Santi Rimadias, Farah Safira Rachmayanti 2018

机译：功能益处的作用分析，象征的益处，体验性和客户满意度成为体内店铺客户的忠诚意图（审查：雅加达地区的车身店）
8. Enhancing TSM&O Strategies through Life Cycle Benefit/Cost Analysis Life Cycle Benefit/Cost Analysis & Life Cycle Assessment of Adaptive Traffic Control Systems and Ramp Metering Systems Life Cycle Benefit/Cost Analysis & Life Cycle Assessment of Adaptive Traffic Control Systems and Ramp Metering Systems Life Cycle Benefit/Cost Analysis & Life Cycle Assessment of Adaptive Traffic Control Systems and Ramp Metering Systems. [R] . Salem, O., Chen, J., Salman, B. 2015

机译：通过生命周期效益/成本分析增强Tsm和O战略生命周期效益/成本分析＆amp;自适应交通控制系统和斜坡计量系统的生命周期评估生命周期效益/成本分析＆amp;自适应交通控制系统和斜坡计量系统的生命周期评估生命周期效益/成本分析＆amp;自适应交通控制系统和斜坡计量系统的生命周期评估。

Benefits

摘要

著录项

相似文献

相关主题

期刊订阅